Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia

Microbiol Immunol. 2001;45(8):605-11. doi: 10.1111/j.1348-0421.2001.tb01291.x.

Abstract

Several studies have indicated that the serine protease urokinase-plasminogen-activator (uPA) is an important factor in host defense against pulmonary pathogens. To gain a better insight into the role of uPA in Pneumocystis carinii (P. carinii) pneumonia (PCP), we evaluated PA production in alveolar macrophages (AMs) obtained from rats with steroid-induced PCP. Treatment with cortisone acetate favored PCP in 91% of rats. In the bronchoalveolar lavage (BAL) samples of immunosuppressed rats both with and without PCP, we observed a decrease in uPA activity as well as a decrease in cell number. Urokinase-PA production by AMs was reduced in rats treated with cortisone alone. However, an increase in cell-associated uPA was observed in rats with PCP. This increase appears to be produced in response to P carinii infection. In fact, when AMs obtained from untreated healthy or immunosuppressed uninfected rats were challenged with P carinii, a significant increase in PA activity in cell lysates was observed, though a lower response was obtained in cortisone-treated animals. Our results suggest that healthy AMs respond to the presence of P carinii with an increase in uPA production and that this response in immunodepressed rat-AMs is partially impaired.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Animals
  • Diet, Protein-Restricted / adverse effects
  • Immunosuppression Therapy / methods
  • Macrophages, Alveolar / immunology*
  • Male
  • Pneumonia, Pneumocystis / immunology*
  • Rats
  • Rats, Sprague-Dawley
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Adrenal Cortex Hormones
  • Urokinase-Type Plasminogen Activator